Note:  All articles are the sole copyright of the respective publishers.  Materials are provided for educational purposes only. Downloading of materials constitutes an agreement that the materials are for personal use only.








Cummings, J.R., Ray, L.A., & Tomiyama, A.J. (2017). Food-alcohol competition: As young females eat more food, do they drink less alcohol? Journal of Health Psychology, 22(5), 674-683.

Yardley, M., & Ray, L.A. (2017). Medications development for the treatment of alcohol use disorder: Insights into the predictive value of animal paradigms and human laboratory models. Addiction Biology, 22(3), 581-615.

Bello, M.S., Pang, R.D., Chasson, G.S., Ray, L.A., & Leventhal, A.M. (2017). Obsessive-Compulsive Symptoms and Negative Affect During Tobacco Withdrawal in a Non-Clinical Sample of African American Smokers. Journal of Anxiety Disorders, 48, 78-86. 

Cservenka, A., Yardley, M.M., & Ray, L.A. (2017). Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. The American Journal on Addictions, 26(5), 516-525. 

Bullock, K., Cservenka, A., & Ray, L.A. (2017). Severity of alcohol dependence is negatively related to hypothalamic and prefrontal cortical gray matter density in heavy drinking smokers. American Journal of Drug and Alcohol Abuse, 43(3), 281-290.

Westman, J., Bujarski, S.E., & Ray, L.A. (2017). Impulsivity moderates subjective responses to alcohol in alcohol dependent individuals. Alcohol & Alcoholism, 52(2), 249-255.

Lim, A., Cservenka, A., & Ray, L.A. (2017). Effects of alcohol dependence severity on neural correlates of delay discounting. Alcohol & Alcoholism, 52(4), 506-515. 

Ray, L.A., Bujarski, S.E., Shoptaw, S., Roche, D.J.O., Heinzerling, K., & Miotto, K. (2017). Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: A randomized, placebo-controlled, human laboratory trial. Neuropsychopharmacology, 42, 1776-1788. 

Ray, L.A., Bujarski, S., Yardley, M.M., Roche, D.J.O., & Hartwell, E. (2017). Differences between treatment-seeking and non-treatment seeking participants in medication studies for alcoholism: Do they matter? American Journal of Drug and Alcohol Abuse, 43, 703-710.

Roche, D.J.O., Worley, M., Courtney, K., Bujarski, S., London, E., Shoptaw, S., Ray, L.A. (2017). Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder. Psychopharmacology, 234(13), 1997-2007.

Cservenka, A., Courtney, K., Ghahremani, D., Hutchison, K.E., & Ray, L.A. (2017). Development, initial testing, and challenges of an ecologically valid reward prediction error fMRI task for alcoholism. Alcohol & Alcoholism, 52(5), 617-624. 





Courtney, K.E., & Ray, L.A. (2016). Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development. Progress in Brain Research, 223, 295-310.Bacio, G.A. & Ray, L.A. (2016). Patterns of drinking initiation among Latino youths: Cognitive and contextual explanations of the immigrant paradox. Journal of Child & Adolescent Substance Abuse, 1-11.Roche, D.J.O., Ray, L.A., Yardley, M.M., & King, A.C. (2016). Current insights into the mechanisms and treatments for heavy-drinking cigarette smokers. Current Addiction Reports, 3(1), 125-137.

Roche, D.J.O., Lunny, K.F., Yardley, M.M., Louie, S.G., Davies, D.L., Miotto K., & Ray L.A. (2016). A Pilot study of the safety and initial efficacy of ivermectin for the treatment of alcohol use disorder. Alcoholism: Clinical and Experimental Research, 40(6), 1312-1320.

Green, R., Bujarski, S., Roche, D.J.O., & Ray, L.A. (2016). Relationship between negative affect and smoking topography in heavy drinking smokers. Addictive Behaviors, 61, 53-57.

Chung, T., Noronha, A., Carroll, K.M., Potenza, M.N., Hutchison, K., Calhoun, V.D., Gabrieli, J.D.E., Morgenstern, J., Nixon, S.J., Wexler, B.E., Brewer, J., Ray, L.A., Filbey, F., Strauman, T.J., Kober, H., & Feldstein Ewing, S.W. (2016). Brain Mechanisms of Change in Addiction Treatment: Models, Methods, and Emerging Findings. Current Addiction Reports, 3(3), 332-342.

Bujarski, S. & Ray, L.A. (2016). Experimental psychopathology paradigms for alcohol use disorder: Applications for translational research. Behaviour Research and Therapy, 86, 11-22.

Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2016). The effects of pharmacological opioid blockade on neural measures of drug cue-reactivity in humans. Neuropsychopharmacology, 41(12), 2872-2881.

Hartwell, E.E., Moallem, N.R., Courtney, K.E., Glasner-Edwards, S., & Ray, L.A. (2016). Sex differences in the association between internalizing symptoms and craving in methamphetamine users. Journal of Addiction Medicine, 10(6), 395-401.







Bidwell, L.C., Knopik, V.S., Audrain-McGovern,J., Glynn, T.R., Spillane, N.S., Ray, L.A., Riggs, N.R., Guillot, C., Pang,R.D., & Leventhal, A.M. (2015). Novelty seeking as a phenotypic marker of adolescent substance use. Substance Abuse: Research and Treatment, 9(Suppl 1), 1-10.

Yardley, M.M., Mirbaba, M.M., & Ray, L.A. (2015). Pharmacological options for smoking cessation in heavy-drinking smokers. CNS Drugs, 29(10), 833-845.

Hartwell, E.E., Bujarski, S., Glasner-Edwards, S., & Ray, L.A. (2015). The association of alcoholism severity with sleep quality in problem alcohol users. Alcohol & Alcoholism, 50(5), 536-541.

Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A. & London, E.D. (2015). Varenicline, naltrexone, and their combination for heavy drinking smokers: Preliminary neuroimaging findings. American Journal of Drug and Alcohol Abuse, 41(1), 35-44.

Courtney, K.E., Ghahremani, D.G., & Ray, L.A. (2015). The effect of alcohol priming on neural markers of alcohol cue-reactivity. American Journal of Drug and Alcohol Abuse, 41(4), 300-308.

Bujarski, S.E., Lau, A., Lee, S., & Ray, L.A. (2015). Genetic and environmental predictors of alcohol use in Asian American young adults. Journal of Studies on Alcohol and Drugs, 76(5), 690-699.


Courtney, K. & Ray, L.A. (2014). Subjective response to alcohol in the lab predicts neural response to alcohol cues. Journal of Studies on Alcohol and Drugs, 75(1), 124-35.

Bacio, G.A., Lunny, K.F., Webb, J.N., & Ray, L.A. (2014). Alcohol use following and alcohol challenge and a brief intervention among alcohol-dependent individuals. American Journal on Addiction, 23(1), 96-101.

Bacio, G.A., Moore, A., Karno, M., & Ray, L.A. (2014). Determinants of problem drinking and depression among Latino day laborers. Substance Use & Misuse, 49(8), 1039-1048.

Miranda Jr., R., Monti, P.M., Ray, L.A., Treloar, H.R., Reynolds, E.K., Ramirez, J., Chun, T., Gwaltney, C.J., Justus, A., Tidey, J., Blanchard, A., & Magill, M. (2014). Characterizing subjective responses to alcohol among adolescent problem drinkers. Journal of Abnormal Psychology, 123(1), 117-29.

Ray, L.A., Bujarski, S., Squeglia, L.M., Ashenhurst, J.R., & Anton, R. (2014). Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol & Alcoholism, 49(3), 261-270.

DeMartini, K.S., Devine, E., DiClemente, C., Martin, D., Ray, L.A., & O’Malley, S.S. (2014). Predictors of pre-treatment commitment to abstinence: Results from the COMBINE Trial. Journal of Studies on Alcohol and Drugs, 75(3), 438-446.

MacKillop, J., Amlung, M.T., Acker, J., Gray, J.C., Brown, C.L., Murphy, J.G., Ray, L.A., & Sweet, L.H. (2014). The neuroeconomics of alcohol demand: an initial investigation of the neural correlates of alcohol cost-benefit decision making in heavy drinking men. Neuropsychopharmacology, 39(8), 1988-1995.

Roche, D., Bujarski, S., Moallem, N., Guzman, I., Shapiro, J., & Ray, L.A. (2014). Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology, 231(14). 2889-2897.

Courtney, K., Ghahremani, D., London, E.D., & Ray, L.A. (2014). The association between cue reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and Alcohol Dependence, 141, 21-26.

Bujarski, S. & Ray, L.A. (2014). Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: An examination of Koob’s allostatic model in humans. Drug and Alcohol Dependence, 140, 161-167.

Ashenhurst, J.R., Bujarski, S., Jentsch, J.D., & Ray, L.A. (2014). Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): Moderation by alcohol problem severity. Experimental and Clinical Psychopharmacology, 22(4), 298-306.

Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A., & London, E.D. (2014). Varenicline, low dose naltrexone, and their combination for heavy drinking smokers: Human laboratory findings. Psychopharmacology, 231, 3843-3853.

Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A. & London, E.D. (2014). Varenicline, naltrexone, and their combination for heavy drinking smokers: Preliminary neuroimaging findings. American Journal of Drug and Alcohol Abuse, 41(1), 35-44.

Bacio, G.A., Guzman, I.Y., Shapiro, J.R., & Ray, L.A. (2014). Differences in quit attempts between Black and White daily smokers: the role of smoking motives. Addictive Behaviors, 39, 1769-1772.

Bujarski, S., Roche, D., Lunny, K., Moallem, N.R., Courtney, K.E., Allen, V., Hartwell, E., Leventhal, A., Rohrbaugh, T., & Ray, L.A. (2014). The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug and Alcohol Dependence, 142, 127-132.

Courtney, K.E. & Ray, L.A. (2014). Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence, 143, 11-21.

Sujan, A. C., Humphreys, K. L., Ray, L. A., & Lee, S. S. (2014). Differential association of child abuse with self-reported versus laboratory-based impulsivity and risk-taking in young adulthood. Child Maltreatment, 19(3-4), 145-155.

Bujarski, S. & Ray, L.A. (2014). Negative affect is associated with alcohol, but not cigarette use in heavy drinking smokers. Addictive Behaviors, 39, 1723-1729.

Miranda Jr., R., Ray, L.A., Blanchard, A., Reynolds, E.K., Monti, P.M., Chun, T., Justus, A., Swift, R. M., Tidey, J., Gwaltney, C.J., & Ramirez, J. (2013). Effects of naltrexone on adolescent alcohol cue-reactivity and sensitivity: An initial randomized trial. Addiction Biology, 19(5), 941-954.

Miranda, R. Jr., Reynolds, E., Ray, L.A., Justus, A., Knopik, V.S., McGeary, J., & Meyerson, L.A. (2013). Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcoholism: Clinical and Experimental Research, 37(2), 325-331

Ray, L.A., Bujarski, S., MacKillop, J., Courtney, K.E., Monti, P.M., & Miotto, K. (2013). Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcoholism: Clinical and Experimental Research, 37(1), E116-E124

Bujarski, S., O’Malley, S., Lunny, K.N., & Ray, L.A. (2013). The effects of drinking goal on treatment outcome for alcoholism. Journal of Consulting and Clinical Psychology 81(1), 13-22.

Courtney, K.E., Ghahremani, D., & Ray, L.A. (2013). Fronto-striatal functional connectivity during response inhibition in alcohol dependence. Addiction Biology, 18(3), 593-604.

Ray, L.A., Lunny, K., Bujarski, S., Moallem, N., Krull, J.L., & Miotto, K. (2013). The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence, 131(1-2), 136-142.

Courtney, K.E., Ashenhurst, J., Bacio, G., Moallem, N., Bujarski, S., Hartwell, E., & Ray, L.A. (2013). Subjective response to alcohol and alcohol craving: Validation of the Desires for Alcohol Questionnaire (DAQ) in the human lab. Journal of Studies on Alcohol and Drugs, 74(5), 797-802.

Ray, L.A., Sehl, M., Bujarski, S., Hutchison, K.E., Blaine, S., & Enoch, M. (2013). The CRHR1 gene, trauma exposure, and alcoholism risk: A test of G × E effects. Genes, Brain & Behavior, 12(4), 361-369.

Hartwell, E. & Ray, L.A. (2013). Sex moderates stress reactivity in heavy drinkers. Addictive Behaviors, 38(11), 2643-2646. 

Moallem, N.R., Courtney, K.E., Bacio, G.A., & Ray, L.A. (2013). Modeling alcoholism severity: An integrative structural equation modeling approach. Frontiers in Psychiatry, 4:75. 

Ray, L.A., Courtney, K., Hutchison, K.E., MacKillop, J., Galvan, A., & Ghahremani, D. (2013). Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcoholism: Clinical and Experimental Research, 37 Suppl 1, E116-24.

Heinzerling, K.G., McCracken, J.T., Swanson, A.N., Ray, L.A., Shoptaw, S.J. (2012). COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp, and methamphetamine dependence treatment response: Preliminary Investigations. Journal of Clinical Psychopharmacology, 32(1):135-137.

Moallem, N. & Ray, L.A. (2012). Quetiapine improves response inhibition in alcohol dependent patients: A placebo-controlled pilot study. Pharmacology, Biochemistry, and Behavior, 100(3), 490-493.

Ray, L.A., Courtney, K.E., Bujarski, S., & Squeglia, L.M. (2012). Pharmacogenetics of alcoholism: a clinical neuroscience perspective. Pharmacogenomics, 13(2), 129-132.

Ray, L.A., Bujarski, S., Chin, P.F., & Miotto, K. (2012). Pharmacogenetics of naltrexone in Asian Americans: A randomized placebo-controlled laboratory study. Neuropsychopharmacology, 37(2), 445-455.

Ray, L. A., Barr, C.S., Blendy, J.A., Oslin, D., Goldman, D., & Anton, R.F. (2012). The role of the Asn40Asp polymorphism of the mu opioid receptor (OPRM1) gene on alcoholism etiology and treatment: a critical review. Alcoholism Clinical and Experimental Research, 36(3), 385-394.

Courtney, K.E., Arellano, R., Barkley-Levenson, E., Gálvan, A., Poldrack, R.A., MacKillop, J., Jentsch, J.D., & Ray, L.A. (2012). The relationship between measures of impulsivity and alcohol misuse: an integrative structural equation modeling approach. Alcoholism Clinical and Experimental Research, 36(6), 923-31.

Leventhal, A.M., Ray, L.A., Rhee, S.H., & Unger, J.B. (2012). Genetic and environmental influences on the association between depressive symptom dimensions and smoking initiation among Chinese adolescent twins. Nicotine & Tobacco Research, 14(5), 559-68.

MacKillop, J., Amlung, M., Wier, L., David, S., Ray, L.A., Bickell, W., & Sweet, L.H. (2012). The neuroeconomics of nicotine dependence: A preliminary study of delay discounting of monetary and cigarette rewards in smokers using fMRI. Psychiatry Research, 202(1), 20-29.

Plebani, J., Ray, L.A., Morean, M.E., Corbin, W.R., MacKillop, J., Amlung, M., King, A.C. (2012). Human laboratory paradigms in alcohol research. Alcoholism Clinical and Experimental Research, 36(6), 972-983.

Bujarski, S., MacKillop, J., & Ray, L.A. (2012). Understanding naltrexone mechanism of action and pharmacogenetics in asian americans via behavior economics: A preliminary study. Experimental and Clinical Psychopharmacology, 20(3), 181-190.

Moallem, N. & Ray, L.A. (2012). Dimensions of impulsivity among heavy drinkers, smokers, and heavy drinking smokers: singular and combined effects. Addictive Behaviors, 37(7), 871-874.

Tartter, M. & Ray, L.A. (2012). A prospective study of laboratory-based stress and alcohol craving in heavy drinkers. Pharmacology, Biochemistry, and Behavior, 101(4), 625-631.

Ray, L. A. (2012). Clinical neuroscience of addiction: Applications to psychological science and practice. Clinical Psychology: Science and Practice, 19(2), 154-166.

Ashenhurst, J.R., Bujarski, S., & Ray, L.A. (2012). Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacology, Biochemistry, and Behavior, 103(2), 253-259.

Bholat, M.A., Ray, L.A., Brensilver, M., Ling, K., & Shoptaw, S. (2012). Integration of behavioral medicine in primary care. Primary Care, 39(4), 605-614.

Ray, L.A. (2011). Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcoholism Clinical and Experimental Research, 35(1), 166-174.

Ray, L.A., Hart, E., Chin, P.F. (2011). Self-rating of the effects of alcohol (SRE): Predictive utility and reliability across interview and self-report administrations. Addictive Behaviors, 36(3), 241-3.

Ray, L.A., Hart, E., Chelminski, I., Young, D., & Zimmerman, M. (2011). Clinical correlates of desire for treatment for current alcohol dependence in patients with a primary psychiatric disorder. American Journal of Drug and Alcohol Abuse, 37(2), 105-110.

Ferriter, C. & Ray, L.A. (2011). Binge eating and binge drinking: an integrative review. Eating Behaviors, 12(2), 99-107.

MacKillop, J., Amlung, M. T., Few, L.R., Ray, L.A., Sweet, L.H., Munafo, M.R. (2011). Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology, 216(3), 305-21.

Hutchison, K.E. & Ray, L.A. (2011). New approaches to identifying rare genetic variants associated with nicotine dependence. Biological Psychiatry, 70(6) 500-501.

Ray, L.A., Chin, P.F., Heydari, A., & Miotto, K. (2011). A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology, 317(3), 341-351.

Tartter, M. & Ray, L.A. (2011). The serotonin transporter polymorphism (5-HTTLPR) and alcohol problems in heavy drinkers: moderation by depressive symptoms. Frontiers in Psychiatry, 2:49, 1-7.

Ashenhurst, J., Jentsch, J.D., & Ray, L.A. (2011). Risk-taking and alcohol use disorders symptomatology in a sample of problem drinkers. Experimental and Clinical Psychopharmacology, 19(5), 361-70.

Miranda, R., Ray, L.A., Justus, A., Meyerson, L.A., Knopik, V.S., McGeary, J., & Monti, P.M. (2010). Initial evidence of an association between OPRM1 gene and adolescent alcohol misuse. Alcoholism Clinical and Experimental Research, 34(1), 1-11.

MacKillop, J., Miranda, R., Jr., Monti, P. M., Ray, L. A., Murphy, J.G., Rohsenow, D. J., McGeary, J. E., Swift, R. M., Tidey, J. W., & Gwaltney, C. J. (2010) Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. Journal of Abnormal Psychology, 119 (1), 106-114.

Ray, L.A., Miranda Jr., R., Tidey, J.W., McGeary, J.E., MacKillop, J., Gwaltney, C.J., Rohsenow, D.J., Swift, R.M., & Monti, P.M. (2010). Polymorphisms of the μ-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. Journal of Abnormal Psychology, 119 (1), 115-125.

Ray, L.A., Chin, P.F., & Miotto, K. (2010). Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. CNS & Neurological Disorders – Drug Targets, 9 (1), 13-22.

Ray, L.A., MacKillop, J., & Monti, P. (2010). Subjective responses to alcohol consumption as endophenotypes: advancing genetics into etiological and treatment models of alcoholism. Subst Use Misuse, 45(11), 1742-1765.

Ray, L.A., Hutchison, K.E., & Tartter, M. (2010). Application of human laboratory models to pharmacotherapy development for alcohol dependence. Current Pharmaceutical Design, 16(19), 2149-2158.

Ray, L.A., Heydari, A., & Zorick, T. (2010). Quetiapine for the treatment of alcoholism: scientific rationale and review of the literature. Drug and Alcohol Review, 29(5), 568-575.

MacKillop, J., O’Hagen, S., Lisman, S.A., Murphy, J.G., Ray, L.A., McGeary, J.E., Tidey, J.W., & Monti, P.E. (2010). Behavioral economic analysis of cue-elicited craving for alcohol. Addiction, 105(9), 1599-607.

Ray, L.A., Hutchison, K.E., Ashenhurst, J., & Morrow, A.L. (2010). Naltrexone selectively elevates GABAergic neurosteroid levels in heavy drinkers with the Asp40 allele of the OPRM1 gene: a pilot investigation. Alcoholism Clinical and Experimental Research, 34(8), 1479-1487.

Ray, L.A., Krull, J.L., Leggio, L. (2010). The effects of naltrexone among alcohol non-abstainers: Results from the COMBINE Study. Frontiers in Psychiatry, 10:3389.

Leventhal, A., Brightman, M., Ameringer, K.J., Greenberg, J., Mickens, L., Ray, L.A., & Sussman, S. (2010). Anhedonia associates with stimulant use and dependence in a population-based sample of American adults. Experimental and Clinical Psychopharmacology, 18(6), 562-569.

Filbey, F., Ray, L.A., Smolen, A., Claus, E., Audette, A., & Hutchison, K.E. (2009). Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotype. Alcoholism Clinical and Experimental Research, 32(7), 1113-1123.

Ray, L.A., Bryan, A., MacKillop, J., McGeary, J., Hesterberg, K. & Hutchison, K.E. (2009). The Dopamine D4 receptor (DRD4) gene exon III polymorphism, problematic alcohol use, and novelty seeking: direct and mediated genetic effects. Addiction Biology, 14(2), 238-244.

MacKillop, J., Murphy, J.G., Tidey, J., Kahler, C., Ray, L.A., & Bickel, W. (2009). Latent structure of the facets of alcohol reinforcement from a behavioral economic demand curve. Psychopharmacology, 203(1), 33-40.

Ray, L.A., MacKillop, J., Leggio, L., Morgan, M., & Hutchison, K.E. (2009). Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacology, Biochemistry, and Behavior, 91, 489-494.

Leventhal, A.M., Kahler, C.W., Ray, L.A., & Zimmerman, M. (2009). Refining the depression-nicotine dependence link: patterns of depressive symptoms in psychiatric outpatients with current, past, and no history of nicotine dependence. Addictive Behaviors, 34(3), 297-303.

Ray, L.A., Miranda, R., Jr., MacKillop, J., McGeary, J. E., Tidey, J. W., Rohsenow, D. J., Gwaltney, C. J., Swift, R. M., & Monti, P. M. (2009). A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Experimental and Clinical Psychopharmacology, 17,122-129.

Ray, L.A., Hutchison, K.E., Leventhal, A., Miranda, R. Jr., Francione, C., Young, D., Chelminski, I., & Zimmerman, M. (2009). Diagnosing alcohol abuse in alcohol dependent individuals: diagnostic and clinical implications. Addictive Behaviors, 34, 587-592.

Magill, M., & Ray, L.A. (2009). Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. Journal of Studies on Alcohol and Drugs, 70, 516-527.

Ray, L.A., & Hutchison, K.E. (2009). Associations among GABRG1, level of response to alcohol, and drinking behaviors. Alcoholism Clinical and Experimental Research, 33(8), 1382-1390.

Leggio, L., Ray, L.A., Kenna, G., and Swift, R.M. (2009). Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcoholism Clinical and Experimental Research, 33(9), 1539-1544.

Leventhal, A.M., Waters, A.J., Kahler, C.W., Ray, L.A., & Sussman, S. (2009). Relations between anhedonia and smoking motivation. Nicotine & Tobacco Research, 11(9), 1047-1054.

Witkiewitz, K., Holmes, A., Ray, L.A., Murphy, J.G., Richardson, H.N., Chen, Y.-C., McDevitt-Murphy, M.E., Cruz, M.T., & Roberto, M. (2009). Young investigator award symposium. Alcohol, 43, 499-508.

Ray, L.A., MacKillop, J., Leventhal, A., & Hutchison, K.E. (2009) Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication. Alcoholism Clinical and Experimental Research, 33(12), 2154-2161.

Ray, L.A., & Oslin, D.W. (2009). Naltrexone for the treatment of alcohol dependence among African Americans: Results from the COMBINE Study. Drug and Alcohol Dependence, 105(3), 256-258.

Ray, L.A., Capone, C., Sheets, E., Young, D., Chelminski, I., & Zimmerman, M. (2009). Posttraumatic stress disorder with and without alcohol use disorders: diagnostic and clinical correlates in a psychiatric sample. Psychiatry Research, 170 (2-3), 278-281.

Miranda, R. Jr., Rohsenow, D.J., Monti, P.M., Tidey, J., & Ray, L.A. (2008). Effects of repeated days of smoking cue-exposure on urge to smoke and physiological reactivity. Addictive Behaviors, 33(2), 347-353.

Miranda, R. Jr., MacKillop J., Monti, P.M., Rohsenow, D.J., Tidey, J., Gwaltney, C., Swift, R., Ray, L.A., & McGeary, J.E. (2008). Effects of topiramate on urge to drink and the subjective effects of alcohol : A preliminary laboratory study. Alcoholism Clinical and Experimental Research, 32(3), 489-497.

Leventhal, A.M., Kahler, C.W., Ray, L.A., Stone, K., & Zimmerman, M. (2008). Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder. American Journal on Addictions, 17(3), 218-223.

Ray, L.A., Miranda Jr., R., Young, D., Chelminski, I., & Zimmerman, M. (2008). Diagnostic orphans for alcohol use disorders in a treatment-seeking psychiatric sample. Drug and Alcohol Dependence, 96(1-2), 187-191.

MacKillop, J., Murphy, J.G., Ray, L.A., Eisenberg, D.T.A., Lisman, S.A., Lum, J.K., & Wilson, D.S. (2008). Further validation of the cigarette purchase task for assessing the relative reinforcing efficacy of nicotine in college smokers. Experimental and Clinical Psychopharmacology, 16(1), 57-65.

Ray, L.A., Kahler, C., Young, D., Chelminski, I., & Zimmerman, M. (2008). The factor structure and severity of DSM-IV alcohol abuse and dependence symptoms in psychiatric outpatients. Journal of Studies on Alcohol and Drugs, 69(4), 496-499.

Ray, L.A., Hutchison, K.E., MacKillop, J., Miranda, R. Jr., Audette, A., Swift, R., & Monti, P.M. (2008). Effects of naltrexone during the descending limb of the blood alcohol curve. American Journal on Addictions, 17(4), 257-264.

Haughey, H.M., Ray, L.A., Finan, P., Villanueva, R., Nicolescu, M., & Hutchison, K.E. (2008). Human gamma-aminobutyric acid A receptor alpha2 gene moderates the acute effects of alcohol and brain mRNA expression. Genes, Brain, and Behavior, 7(4), 447-454.

Bryan, A., Ray, L.A., & Cooper, M.L. (2007). Alcohol use and protective sexual behaviors among high-risk adolescents: A prospective analysis. Journal of Studies on Alcohol and Drugs, 68(3), 327-335.

Ray, L.A., Meskew-Stacer, S., & Hutchison, K.E. (2007). The relationship between prospective self-rating of alcohol sensitivity and craving and experimental results from two alcohol challenge studies. Journal of Studies on Alcohol and Drugs, 68(3), 379-384.

Ray, L.A., Rhee, S.H., Stallings, M.S., Knopik, V., & Hutchison, K.E. (2007). Examining the heritability of a laboratory-based smoking endophenotype: Initial Results from an experimental twin study. Twin Research and Human Genetics, 10(4), 546-553.

Ray, L.A., Miranda, R. Jr., Kahler, C.M., Leventhal, A.M., Monti, P.M., Swift, R., & Hutchison, K.E. (2007). Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes: A pilot study. Psychopharmacology, 193(4), 449-456.

Ray, L.A., & Hutchison, K.E. (2007). Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: A double-blind placebo-controlled study. Archives of General Psychiatry, 64(9), 1069-1077.

Ray, L.A., MacKillop, J., & Hutchison, K.E. (2007). Pharmacogenetics of the μ-opioid receptor and the treatment of addictions. Personalized Medicine, 4(2), 217-220.

Hutchison, K.E., Ray, L.A., Sandman, E., Rutter, M.C., Peters, A., & Swift, R. (2006). The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology, 31, 1310-1317.

Ray, L.A., McGeary, J., Marshall, E., & Hutchison, K.E. (2006). Risk factors for alcohol misuse: Examining heart rate response to alcohol, alcohol sensitivity, and personality constructs. Addictive Behaviors, 31(11), 1959-1973.

Ray, L.A., Hutchison, K.E., & Bryan, A. (2006). Psychosocial predictors of treatment outcome, dropout, and change processes in a pharmacological clinical trial for alcohol dependence. Addictive Disorders and Their Treatment, 5(4), 179-190.

Hines, L., Ray, L.A., Hutchison, K.E., & Tabakoff, B. (2005). Alcoholism: The dissection for endophenotypes. Dialogues in Clinical Neuroscience, 7(3), 153-163.

Ray, L.A., & Hutchison, K. E. (2004). A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcoholism Clinical and Experimental Research, 28, 1789-1795.

Fromme, K., de Witt, H., Hutchison, K.E., Ray, L.A., Corbin, W.R., Cook, T.A., & Wall, T.L. (2004). Biological and behavioral markers of alcohol sensitivity. Alcoholism Clinical and Experimental Research, 28(2), 247-256.